GLICLAGLAZE DAPA 60-10

GLICLAGLAZE DAPA 60-10 is a combination medication containing Gliclazide SR 60 mg and Dapagliflozin 10 mg, developed to support effective blood glucose control in adults with Type 2 Diabetes Mellitus. By combining two clinically established antidiabetic agents with complementary mechanisms of action, GLICLAGLAZE DAPA 60-10 helps patients achieve better glycemic control while supporting overall metabolic health.

This innovative formulation is designed for healthcare professionals seeking reliable and effective diabetes management options and for patients who require comprehensive blood sugar control when diet, exercise, and monotherapy are not sufficient.

What is GLICLAGLAZE DAPA 60-10?

GLICLAGLAZE DAPA 60-10 is a fixed-dose combination tablet that contains:

• Gliclazide SR 60 mg
• Dapagliflozin 10 mg

The combination works through two distinct pathways to help lower blood glucose levels:

• Gliclazide SR stimulates insulin secretion from pancreatic beta cells.
• Dapagliflozin promotes glucose excretion through the kidneys by inhibiting sodium-glucose co-transporter 2 (SGLT2).

Together, these mechanisms provide comprehensive glycemic control for patients with Type 2 Diabetes Mellitus.

How GLICLAGLAZE DAPA 60-10 Works

Gliclazide SR 60 mg

Gliclazide belongs to the sulfonylurea class of medications. It helps lower blood sugar by stimulating the pancreas to release insulin. The sustained-release formulation ensures gradual drug release, providing consistent blood glucose control throughout the day.

Dapagliflozin 10 mg

Dapagliflozin is an SGLT2 inhibitor that works independently of insulin. It reduces blood glucose levels by preventing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine.

Dual Mechanism Advantage

The combination offers enhanced efficacy because:

• Targets multiple pathways involved in glucose regulation
• Improves fasting and postprandial blood sugar levels
• Supports long-term glycemic management
• May help reduce the need for multiple medications
• Provides convenient once-daily dosing in many treatment plans

Benefits of GLICLAGLAZE DAPA 60-10

Effective Blood Sugar Control

The combination of Gliclazide SR and Dapagliflozin helps maintain healthy blood glucose levels throughout the day, reducing fluctuations and improving diabetes management.

Improved HbA1c Reduction

Regular use as prescribed may contribute to significant reductions in HbA1c levels, helping patients achieve recommended glycemic targets.

Sustained Release Technology

The SR formulation of Gliclazide ensures controlled drug release, improving therapeutic effectiveness and patient convenience.

Comprehensive Diabetes Management

By addressing insulin secretion and glucose elimination simultaneously, GLICLAGLAZE DAPA 60-10 provides a balanced approach to diabetes care.

Enhanced Patient Compliance

The fixed-dose combination reduces pill burden and simplifies treatment regimens, encouraging better adherence to prescribed therapy.

Potential Weight Management Support

Dapagliflozin may contribute to modest weight reduction in some patients due to increased urinary glucose excretion.

Indications

GLICLAGLAZE DAPA 60-10 is indicated for:

Type 2 Diabetes Mellitus

It is prescribed as an adjunct to:

• Healthy diet
• Regular physical activity
• Lifestyle modifications

The medication may be recommended when blood glucose control is not adequately achieved with single-agent therapy.

Why Choose GLICLAGLAZE DAPA 60-10?

Healthcare professionals prefer combination therapies because they can address multiple aspects of diabetes simultaneously.

Key Advantages

• Dual-action glucose-lowering mechanism
• Sustained-release formulation for prolonged efficacy
• Convenient fixed-dose combination
• Supports comprehensive glycemic control
• Suitable for long-term diabetes management under medical supervision
• Helps improve treatment adherence

Role of Gliclazide SR in Diabetes Care

Gliclazide SR has been widely used in Type 2 Diabetes management due to its effectiveness and predictable glucose-lowering action.

Clinical Benefits of Gliclazide SR

• Stimulates insulin release when needed
• Improves fasting blood glucose levels
• Supports long-term glycemic management
• Sustained-release formulation enhances convenience
• Proven efficacy in diabetes treatment

Its controlled-release technology helps maintain stable therapeutic levels, reducing significant blood glucose fluctuations.

Role of Dapagliflozin in Modern Diabetes Treatment

Dapagliflozin represents a newer generation of oral antidiabetic therapy that works independently of insulin pathways.

Benefits of Dapagliflozin

• Promotes urinary glucose excretion
• Helps lower blood sugar levels
• Works throughout the day
• Complements other diabetes medications
• Provides additional metabolic advantages

Its unique mechanism makes it an effective partner with sulfonylurea therapy in appropriate patients.

Importance of Combination Therapy in Type 2 Diabetes

Type 2 Diabetes is a progressive metabolic disorder that often requires multiple therapeutic approaches.

Why Combination Therapy Matters

Different medications target different underlying causes of diabetes:

• Reduced insulin secretion
• Increased glucose production
• Insulin resistance
• Excess glucose reabsorption in kidneys

GLICLAGLAZE DAPA 60-10 combines two proven therapies to help address these challenges effectively.

Recommended Usage

GLICLAGLAZE DAPA 60-10 should be taken exactly as prescribed by a qualified healthcare professional.

General Administration Guidelines

• Take the tablet whole with water.
• Do not crush or chew sustained-release tablets.
• Follow the prescribed dosage schedule.
• Maintain a balanced diet and regular exercise program.
• Monitor blood glucose levels as advised by your physician.

Always follow your healthcare provider's instructions regarding dosage and treatment duration.

Supporting Healthy Diabetes Management

While medication plays a crucial role, optimal diabetes control also requires healthy lifestyle practices.

Healthy Lifestyle Recommendations

Balanced Nutrition

Focus on:

• Whole grains
• Fresh vegetables
• Lean proteins
• High-fiber foods
• Controlled carbohydrate intake

Regular Physical Activity

Exercise helps:

• Improve insulin sensitivity
• Support weight management
• Enhance cardiovascular health
• Improve overall metabolic function

Routine Monitoring

Regular blood glucose monitoring helps evaluate treatment effectiveness and maintain target glycemic goals.

Safety Information

GLICLAGLAZE DAPA 60-10 should only be used under medical supervision.

Important Considerations

Patients should inform their healthcare provider about:

• Existing medical conditions
• Kidney disorders
• Liver disorders
• Current medications
• Allergies
• Pregnancy or breastfeeding status

Regular medical follow-up is important to ensure safe and effective treatment outcomes.

Storage Instructions

Store GLICLAGLAZE DAPA 60-10:

• In a cool and dry place
• Away from direct sunlight
• Below the recommended storage temperature
• Out of reach of children

Always keep the product in its original packaging until use.

Conclusion

GLICLAGLAZE DAPA 60-10 (Gliclazide SR 60 mg & Dapagliflozin 10 mg Tablets) is a scientifically designed combination therapy that supports comprehensive Type 2 Diabetes management. By combining the proven efficacy of Gliclazide SR with the innovative glucose-lowering action of Dapagliflozin, it offers a powerful approach to achieving and maintaining glycemic control.

Its dual-action mechanism, sustained-release technology, and convenient fixed-dose formulation make GLICLAGLAZE DAPA 60-10 a valuable option for healthcare professionals seeking effective diabetes treatment solutions. When used under medical supervision and alongside a healthy lifestyle, GLICLAGLAZE DAPA 60-10 can play an important role in modern diabetes care.